158 related articles for article (PubMed ID: 38343210)
1. Deconvolution-Based Pharmacokinetic Analysis to Improve the Prediction of Pathological Information of Breast Cancer.
Zhang L; Fan M; Li L
J Imaging Inform Med; 2024 Feb; 37(1):13-24. PubMed ID: 38343210
[TBL] [Abstract][Full Text] [Related]
2. Efficient estimation of pharmacokinetic parameters from breast dynamic contrast-enhanced MRI based on a convolutional neural network for predicting molecular subtypes.
Zhang L; Fan M; Li L
Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37983902
[No Abstract] [Full Text] [Related]
3. Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer.
Zhang L; Fan M; Wang S; Xu M; Li L
J Magn Reson Imaging; 2022 Jun; 55(6):1636-1647. PubMed ID: 34773446
[TBL] [Abstract][Full Text] [Related]
4. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
5. Radiomic analysis of imaging heterogeneity in tumours and the surrounding parenchyma based on unsupervised decomposition of DCE-MRI for predicting molecular subtypes of breast cancer.
Fan M; Zhang P; Wang Y; Peng W; Wang S; Gao X; Xu M; Li L
Eur Radiol; 2019 Aug; 29(8):4456-4467. PubMed ID: 30617495
[TBL] [Abstract][Full Text] [Related]
6. Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer.
Zhou X; Gao F; Duan S; Zhang L; Liu Y; Zhou J; Bai G; Tao W
Phys Eng Sci Med; 2020 Jun; 43(2):517-524. PubMed ID: 32524436
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.
Feng S; Yin J
Quant Imaging Med Surg; 2023 Oct; 13(10):6735-6749. PubMed ID: 37869317
[TBL] [Abstract][Full Text] [Related]
8. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
Wu J; Gong G; Cui Y; Li R
J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
[TBL] [Abstract][Full Text] [Related]
9. Dynamic contrast-enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features.
Li J; Xue F; Xu X; Wang Q; Zhang X
Exp Ther Med; 2020 Oct; 20(4):3643-3652. PubMed ID: 32855716
[TBL] [Abstract][Full Text] [Related]
10. Texture Analysis of Breast DCE-MRI Based on Intratumoral Subregions for Predicting HER2 2+ Status.
Lu H; Yin J
Front Oncol; 2020; 10():543. PubMed ID: 32373531
[No Abstract] [Full Text] [Related]
11. MRI-based machine learning models predict the malignant biological behavior of meningioma.
Li M; Liu L; Qi J; Qiao Y; Zeng H; Jiang W; Zhu R; Chen F; Huang H; Wu S
BMC Med Imaging; 2023 Sep; 23(1):141. PubMed ID: 37759192
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging at 7T for Breast Cancer Diagnosis and Characterization.
Ochoa-Albiztegui RE; Sevilimedu V; Horvat JV; Thakur SB; Helbich TH; Trattnig S; Morris EA; Reiner JS; Pinker K
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327532
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
[TBL] [Abstract][Full Text] [Related]
14. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
16. Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Li Z; Zhao W; He B; Koh TS; Li Y; Zeng Y; Zhang Z; Zhang J; Hou Z
Contrast Media Mol Imaging; 2020; 2020():8843084. PubMed ID: 33299387
[TBL] [Abstract][Full Text] [Related]
17. Radiomic machine learning for predicting prognostic biomarkers and molecular subtypes of breast cancer using tumor heterogeneity and angiogenesis properties on MRI.
Lee JY; Lee KS; Seo BK; Cho KR; Woo OH; Song SE; Kim EK; Lee HY; Kim JS; Cha J
Eur Radiol; 2022 Jan; 32(1):650-660. PubMed ID: 34226990
[TBL] [Abstract][Full Text] [Related]
18. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
19. Radiomics of dynamic contrast-enhanced magnetic resonance imaging parametric maps and apparent diffusion coefficient maps to predict Ki-67 status in breast cancer.
Feng S; Yin J
Front Oncol; 2022; 12():847880. PubMed ID: 36895526
[TBL] [Abstract][Full Text] [Related]
20. Fractal Dimension Analysis of Pixel Dynamic Contrast Enhanced-Magnetic Resonance Imaging Pharmacokinetic Parameters for Discrimination of Benign and Malignant Breast Lesions.
Sherminie LPG; Jayatilake ML
JCO Clin Cancer Inform; 2023 Jan; 7():e2200101. PubMed ID: 36745858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
